Okomera Opens Pre-Orders For Ocentra, The Central Engine For Automated Organoid Screening

2025-06-09 07:31:38

(MENAFN- PR Newswire) Powered by microfluidics, Ocentra is a plug-and-play benchtop instrument that automates organoid formation and multiplexed screenings . Requiring as few as 50 cells per organoid, it enables versatile assays on fresh or frozen biopsies -including small-molecule, biologic, immune co-culture, and CRISPR with lentiviruses. After each run, imaging data flow seamlessly into Okomera's analysis software, Okomera AI , giving researchers an end-to-end path from sample to insight.

"Ocentra brings simplicity and scalability to complex biology," said Sidarth Radjou, CEO of Okomera . "Researchers can now shorten the journey from sample to actionable data."

Dr Pierre Savagner , INSERM Researcher at Gustave Roussy, the system's first user, added:

"I first saw this technology in 2019 and recognized a strong potential for preclinical ex-vivo studies. Ocentra could make that vision a robust, user-friendly reality."

Where to meet Okomera:
The team will be exhibiting at VivaTech, Paris (11–14 June) and attend the BIO International Convention, Boston (16 –19 June) and welcomes attendees to discuss pre-order opportunities.

For media enquiries or to schedule a meeting, contact Sidarth Radjou (CEO) at [email protected] .

About Okomera
Okomera builds smart instruments that combine microfluidics, automation, and AI to transform organoid screening in drug discovery.

Photo -
Logo -

SOURCE Okomera

MENAFN09062025003732001241ID1109651196

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.